20-8132679-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015192.4(PLCB1):​c.28G>T​(p.Ala10Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000291 in 1,612,474 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 4 hom. )

Consequence

PLCB1
NM_015192.4 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 8.49
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.041476816).
BP6
Variant 20-8132679-G-T is Benign according to our data. Variant chr20-8132679-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 410075.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000131 (20/152168) while in subpopulation SAS AF= 0.00062 (3/4836). AF 95% confidence interval is 0.000169. There are 0 homozygotes in gnomad4. There are 13 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.28G>T p.Ala10Ser missense_variant Exon 1 of 32 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.28G>T p.Ala10Ser missense_variant Exon 1 of 33 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.28G>T p.Ala10Ser missense_variant Exon 1 of 32 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000319
AC:
79
AN:
247682
Hom.:
1
AF XY:
0.000461
AC XY:
62
AN XY:
134598
show subpopulations
Gnomad AFR exome
AF:
0.0000629
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00190
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000162
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000307
AC:
449
AN:
1460306
Hom.:
4
Cov.:
30
AF XY:
0.000377
AC XY:
274
AN XY:
726536
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000672
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00202
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000231
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152168
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000620
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000235
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000230
Hom.:
0
Bravo
AF:
0.000170
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000330
AC:
40
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 12 Uncertain:1Benign:1
Aug 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PLCB1 NM_015192.3 exon 1 p.Ala10Ser (c.28G>T): This variant has not been reported in the literature but is present in 0.02% (16/64558) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/20-8132679-G-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:410075). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Inborn genetic diseases Uncertain:1
Dec 18, 2017
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.A10S variant (also known as c.28G>T), located in coding exon 1 of the PLCB1 gene, results from a G to T substitution at nucleotide position 28. The alanine at codon 10 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jan 13, 2025
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

See Variant Classification Assertion Criteria. -

PLCB1-related disorder Benign:1
Jun 28, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.25
.;T;.;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
.;D;D;D;D
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.041
T;T;T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
1.7
L;L;.;.;L
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.75
N;N;.;.;N
REVEL
Benign
0.14
Sift
Benign
0.11
T;T;.;.;T
Sift4G
Benign
0.32
T;T;D;D;T
Polyphen
1.0
D;P;.;.;D
Vest4
0.43
MVP
0.37
MPC
0.095
ClinPred
0.093
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150241349; hg19: chr20-8113326; COSMIC: COSV62069413; API